Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (يفتح نافذة جديدة)

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A

Source‎: Br J Haematol. 2022;197(3):359-66.

مفهرسة‎: PubMed 35179784

DOI‎: 10.1111/bjh.18081

https://pubmed.ncbi.nlm.nih.gov/35179784/ (يفتح نافذة جديدة)

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (يفتح نافذة جديدة)

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Source‎: Br J Haematol 1998;103(4):1061-3.

مفهرسة‎: PubMed 9886319

https://www.ncbi.nlm.nih.gov/pubmed/9886319 (يفتح نافذة جديدة)

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (يفتح نافذة جديدة)

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

Source‎: Ann Intern Med 2007;146(1):25-33.

مفهرسة‎: PubMed 17200219

https://www.ncbi.nlm.nih.gov/pubmed/17200219 (يفتح نافذة جديدة)

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (يفتح نافذة جديدة)

Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG

Source‎: Lancet Haematol 2020;7(9):e640-8.

مفهرسة‎: PubMed 32853584

DOI‎: 10.1016/S2352-3026(20)30227-1

https://www.ncbi.nlm.nih.gov/pubmed/32853584 (يفتح نافذة جديدة)

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (يفتح نافذة جديدة)

Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M.

Source‎: J Pediatr 1993;123(6):989-95.

مفهرسة‎: PubMed 8229536

https://www.ncbi.nlm.nih.gov/pubmed/8229536 (يفتح نافذة جديدة)

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (يفتح نافذة جديدة)

Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G.

Source‎: Ann Hematol 2004;83(12):764-8.

مفهرسة‎: PubMed 15309522

DOI‎: 10.1007/s00277-004-0908-1

https://www.ncbi.nlm.nih.gov/pubmed/15309522 (يفتح نافذة جديدة)

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (يفتح نافذة جديدة)

British Committee for Standards in Haematology General Haematology Task Force.

Source‎: Br J Haematol 2003;120(4):574-96.

مفهرسة‎: PubMed 12588344

https://www.ncbi.nlm.nih.gov/pubmed/12588344 (يفتح نافذة جديدة)

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (يفتح نافذة جديدة)

Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS

Source‎: Blood Adv 2020;4(7):1492-1500.

مفهرسة‎: PubMed 32282882

DOI‎: 10.1182/bloodadvances.2019001343

https://www.ncbi.nlm.nih.gov/pubmed/32282882 (يفتح نافذة جديدة)

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (يفتح نافذة جديدة)

Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.

Source‎: N Engl J Med 2003;349(9):831-6.

مفهرسة‎: PubMed 12944568

DOI‎: 10.1056/NEJMoa030254

https://www.ncbi.nlm.nih.gov/pubmed/12944568 (يفتح نافذة جديدة)

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (يفتح نافذة جديدة)

Ghanima W, Godeau B, Cines DB, Bussel JB.

Source‎: Blood 2012;120(5):960-9.

مفهرسة‎: PubMed 22740443

DOI‎: 10.1182/blood-2011-12-309153

https://www.ncbi.nlm.nih.gov/pubmed/22740443 (يفتح نافذة جديدة)

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (يفتح نافذة جديدة)

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR

Source‎: Br J Haematol 2017;178(6):959-70.

مفهرسة‎: PubMed 28573819

DOI‎: 10.1111/bjh.14788

https://www.ncbi.nlm.nih.gov/pubmed/28573819 (يفتح نافذة جديدة)

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (يفتح نافذة جديدة)

Kojouri K, Vesely SK, Terrell DR, George JN.

Source‎: Blood 2004;104(9):2623-34.

مفهرسة‎: PubMed 15217831

DOI‎: 10.1182/blood-2004-03-1168

https://www.ncbi.nlm.nih.gov/pubmed/15217831 (يفتح نافذة جديدة)

Romiplostim or standard of care in patients with immune thrombocytopenia. (يفتح نافذة جديدة)

Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.

Source‎: N Engl J Med 2010;363(20):1889-99.

مفهرسة‎: PubMed 21067381

DOI‎: 10.1056/NEJMoa1002625

https://www.ncbi.nlm.nih.gov/pubmed/21067381 (يفتح نافذة جديدة)

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (يفتح نافذة جديدة)

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party.

Source‎: Blood 2007;109(4):1401-7.

مفهرسة‎: PubMed 17077333

DOI‎: 10.1182/blood-2005-12-015222

https://www.ncbi.nlm.nih.gov/pubmed/17077333 (يفتح نافذة جديدة)

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (يفتح نافذة جديدة)

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology.

Source‎: Blood 2011;117(16):4190-207.

مفهرسة‎: PubMed 21325604

DOI‎: 10.1182/blood-2010-08-302984

https://www.ncbi.nlm.nih.gov/pubmed/21325604 (يفتح نافذة جديدة)

American Society of Hematology 2019 guidelines for immune thrombocytopenia. (يفتح نافذة جديدة)

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK

Source‎: Blood Adv 2019;3(23):3829-66.

مفهرسة‎: PubMed 31794604

DOI‎: 10.1182/bloodadvances.2019000966

https://www.ncbi.nlm.nih.gov/pubmed/31794604 (يفتح نافذة جديدة)

International consensus report on the investigation and management of primary immune thrombocytopenia. (يفتح نافذة جديدة)

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.

Source‎: Blood 2010;115(2):168-86.

مفهرسة‎: PubMed 19846889

DOI‎: 10.1182/blood-2009-06-225565

https://www.ncbi.nlm.nih.gov/pubmed/19846889 (يفتح نافذة جديدة)

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (يفتح نافذة جديدة)

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Source‎: Blood 1997;89(8):2689-700.

مفهرسة‎: PubMed 9108386

https://www.ncbi.nlm.nih.gov/pubmed/9108386 (يفتح نافذة جديدة)